Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease

被引:72
作者
Hostalkova, Anna [1 ]
Marikova, Jana [2 ]
Opletal, Lubomir [1 ]
Korabecny, Jan [3 ,4 ]
Hulcova, Daniela [1 ,5 ]
Kunes, Jiri [2 ]
Novakova, Lucie [6 ]
Perez, Daniel I. [7 ]
Jun, Daniel [3 ]
Kucera, Tomas [3 ]
Andrisano, Vincenza [8 ]
Siatka, Tomas [5 ]
Cahlikova, Lucie [1 ]
机构
[1] Charles Univ Prague, Fac Pharm, Dept Pharmaceut Bot, ADINACO Res Grp, Heyrovskeho 1203, Hradec Kralove 50005, Czech Republic
[2] Charles Univ Prague, Fac Pharm, Dept Organ & Bioorgan Chem, Heyrovskeho 1203, Hradec Kralove 50005, Czech Republic
[3] Dept Toxicoloxy & Mil Pharm, Trebesska 1575, Hradec Kralove 50005, Czech Republic
[4] Univ Hosp Hradec Kralove, Biomed Res Ctr, Sokolska 581, Hradec Kralove 50005, Czech Republic
[5] Charles Univ Prague, Fac Pharm, Dept Pharmacognosy, Heyrovskeho 1203, Hradec Kralove 50005, Czech Republic
[6] Charles Univ Prague, Fac Pharm, Dept Analyt Chem, Heyrovskeho 1203, Hradec Kralove 50005, Czech Republic
[7] CSIC, Ctr Invest Biol, Ave Ramiro de Maeztu 9, Madrid 28040, Spain
[8] Univ Bologna, Dept Life Qual Studies, Corso DAugusto 237, I-47921 Rimini, Italy
来源
JOURNAL OF NATURAL PRODUCTS | 2019年 / 82卷 / 02期
关键词
PROLYL OLIGOPEPTIDASE; ACETYLCHOLINESTERASE; INHIBITORS; CHOLINESTERASES; DRUGS; BUTYRYLCHOLINESTERASE; OPTIMIZATION; SPECTROSCOPY; DERIVATIVES; ATTENTION;
D O I
10.1021/acs.jnatprod.8b00592
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
Three new alkaloids, bersavine (3), muraricine (4), and berbostrejdine (8), together with seven known isoquinoline alkaloids (1-2, 5-7, 9, and 10) were isolated from an alkaloidal extract of the root bark of Berberis vulgaris. The structures of the isolated compounds were determined by spectroscopic methods, including 1D and 2D NMR techniques, HRMS, and optical rotation, and by comparison a of the obtained data with those in the literature. The NMR data of berbamine (5), aromoline (6), and obamegine (7) were completely assigned employing 2D NMR experiments. Alkaloids isolated in sufficient amounts were evaluated for their in vitro acetylcholinesterase, butyrylcholinesterase (BuChE), prolyl oligopeptidase, and glycogen synthase kinase-3 beta inhibitory activities. Selected compounds were studied for their ability to permeate through the blood-brain barrier. Significant human BuChE (hBuChE) inhibitory activity was demonstrated by 6 (IC50 = 0.82 +/- 0.10 mu M). The in vitro data were further supported by computational analysis that showed the accommodation of 6 in the active site of hBuChE.
引用
收藏
页码:239 / 248
页数:10
相关论文
共 61 条
[1]
[Anonymous], 2017, SUNSCR MON VERS 2 0
[2]
[Anonymous], 2016, DISC STUD VIS V 17 2
[3]
Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors [J].
Babkova, Katerina ;
Korabecny, Jan ;
Soukup, Ondrej ;
Nepovimova, Eugenie ;
Jun, Daniel ;
Kuca, Kamil .
FUTURE MEDICINAL CHEMISTRY, 2017, 9 (10) :1015-1038
[4]
THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[5]
Bastos IMD, 2013, CURR MED CHEM, V20, P3103
[6]
PHLEBICINE, A NEW BIPHENYLBISBENZYLISOQUINOLINE ALKALOID FROM CREMASTOSPERMA-POLYPHLEBUM [J].
CAVA, MP ;
WAKISAKA, K ;
NOGUCHI, I ;
EDIE, DL ;
DAROCHA, AI .
JOURNAL OF ORGANIC CHEMISTRY, 1974, 39 (24) :3588-3591
[7]
8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models [J].
Cheng, Zhe ;
Chen, An-Feng ;
Wu, Fang ;
Sheng, Li ;
Zhang, Han-Kun ;
Gu, Min ;
Li, Yuan-Yuan ;
Zhang, Li-Na ;
Hu, Li-Hong ;
Li, Jing-Ya ;
Li, Jia .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (16) :5915-5924
[8]
Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands [J].
Cheung, Jonah ;
Rudolph, Michael J. ;
Burshteyn, Fiana ;
Cassidy, Michael S. ;
Gary, Ebony N. ;
Love, James ;
Franklin, Matthew C. ;
Height, Jude J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) :10282-10286
[9]
Predicting blood-brain barrier permeation from three-dimensional molecular structure [J].
Crivori, P ;
Cruciani, G ;
Carrupt, PA ;
Testa, B .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (11) :2204-2216
[10]
Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials (Publication with Expression of Concern. See vol. 13, pg. 177, 2018) [J].
Derosa, Giuseppe ;
Maffioli, Pamela ;
Cicero, Arrigo F. G. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (08) :1113-1124